pronged campaign to expand into new markets that offer significant growth potential.
 | Surgical Stapling A medical curiosity until 1967, when USSC introduced the world's first practical instrument, surgical stapling reduces operating time and blood loss, minimizes tissue trauma and speeds healing. USSC is the market leader. |
 | Endoscopic Instrumentation In 1990, USSC's groundbreaking instrumentation for laparoscopic gallbladder removal sparked a revolution in the way surgery is performed. Today, the company continues to lead the market as its products are applied to a widening range of new surgical specialties. |
 | Sutures Despite new technologies for wound closure, the suture market exceeds $1.3 billion annually. USSC, which introduced its first line of sutures in 1991, continues to increase its share of suture sales worldwide. Today sutures represent a $100 million business to USSC. |
 | Orthopedic And Neurosurgery In 1995, USSC purchased Surgical Dynamics, Inc. (SDI). Today SDI is expanding its line of advanced orthopedic and neurosurgical products led by the Ray TFC device for treatment of degenerative disc disease. |
 | Cardiovascular Surgery/ Interventional Cardiology USSC's commitment to become a major player in these multi-billion dollar markets has generated a number of compelling new products, including the first full line of instruments for minimally invasive coronary bypass procedures. Additional products for interventional cardiology and cardio- vascular surgery are in development. |
 USSC's ABBI System | Women's Health Care Women's health care is emerging as one of the most important areas in the health care industry. USSC pioneered laparoscopic procedures in gynecology and recently introduced the ABBI system for minimally invasive breast biopsy. Other new technologies are in development. |
